Kab mob qog ntshav Lymphoblastic loj heev (T-ALL)-08

Yesheng los ntawm Fujian hais tias, "Yog tias kuv tau paub txog CAR-T ntawm BIOOCUS Medical Group, kuv yuav tau tuaj ua ntej dua."

Thaum lub Cuaj Hlis 2017, Yesheng tau muaj pob khaus ntawm lub ntsej muag, uas maj mam kis mus rau lwm qhov thiab sib xyaw ua tej daim me me. Txog rau thaum Lub Ob Hlis 28, 2018, kev kuaj pob txha tau lees paub tias muaj "mob leukemia T-cell lymphoblastic mob hnyav" tom qab ntau zaus kho mob chemotherapy, nrog rau kev kuaj xyuas tsis pom muaj cov tshuaj seem. Tag nrho cov tshuaj tau raug tso tseg thaum Lub Rau Hli 2019.

Thaum lub Tsib Hlis 2021, Yesheng tau tuaj txog nrog cov qog nqaij hlav hauv thaj tsam qhov ncauj thiab caj dab thiab cov qog ntshav ntawm caj dab loj hlob. Kev kuaj mob dua ntawm cov pob txha tau lees paub tias muaj tus kab mob leukemia rov qab los tag nrho. Thaum lub Tsib Hlis 28, Yesheng tau raug xa mus rau Chav Kho Mob Ntshav Thib Ob kom nkag mus. Tom qab kev kuaj mob tag nrho, qhov kev kuaj mob tau hloov kho mus ua "acute leukemia (T/myeloid biphenotypic)."

Ib lub voj voog ntawm kev kho mob chemotherapy tsis tau ua rau cov pob txha rov zoo li qub. Thaum Lub Xya Hli 27, Yesheng tau txais CD7 CAR-T cell infusion, tom qab ntawd tau txais chemotherapy ua ke nrog kev kho mob CD7 CAR-T cell autologous. Kaum tsib hnub tom qab kev txhaj tshuaj, kev kuaj mob pob txha qhia tias tsis muaj kab mob seem, nrog rau qib 1 cytokine release syndrome (CRS) thiab tsis muaj kev phiv tshuaj ntawm lub paj hlwb.